Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort

Blood blood.2024025834.

https://doi.org/10.1182/blood.2024025834

Published: 2024

Includes: Supplemental data

Journal Articles

A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx

Lemchukwu Amaeshi, Alex Sisto, Lauren Laufer, Kateryna Fedorov, Rosmi Mathew, David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis L Cooper, Marina Y. Konopleva, Bruce Rapkin, Amit Verma, Aditi Shastri, Nishi Shah

Blood (2023) 142 (Supplement 1): 7397.

https://doi.org/10.1182/blood-2023-188024

Published: 2023

Journal Articles

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

Ioannis Mantzaris, Mendel Goldfinger, Nishi Shah, Annemarie Munoz, Aradhika Dhawan, Nicole Chambers, Karen Fehn, Joel Victor, Aditi Shastri, Kira Gritsman, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Amit Verma, Mimi Kim, Ulrich Steidl, Eric J Feldman, Marina Y. Konopleva

Blood (2023) 142 (Supplement 1): 4257.

https://doi.org/10.1182/blood-2023-188176

Published: 2023

Journal Articles

Comparison of the Prognostic Performance of European Leukemianet 2017 and 2022 Classifications in a Minority-Rich Population of Adult Patients with Acute Myeloid Leukemia

Kateryna Fedorov, Alexander Sisto, Josette Kamel, Mark Forsberg, Kith Pradhan, Nishi Shah, Aditi Shastri, Mendel Goldfinger, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Kira Gritsman, Amit K. Verma, Eric J Feldman, Marina Y. Konopleva, Ioannis Mantzaris

Blood (2023) 142 (Supplement 1): 2968.

https://doi.org/10.1182/blood-2023-180856

Published: 2023

Journal Articles

Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population

Lauren Laufer, Lemchukwu Amaeshi, Alex Sisto, Kateryna Fedorov, Rosmi Mathew, David Levitz, Ioannis Mantzaris, Noah Kornblum, Mendel Goldfinger, Alejandro Sica, Dennis L Cooper, Marina Y. Konopleva, Bruce Rapkin, Amit Verma, Aditi Shastri, Nishi Shah

Blood (2023) 142 (Supplement 1): 2350.

https://doi.org/10.1182/blood-2023-186867

Published: 2023

Journal Articles

Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial

Blood (2023) 142 (Supplement 1): 4258.

https://doi.org/10.1182/blood-2023-185379

Published: 2023

Journal Articles

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

Blood (2023) 142 (Supplement 1): 545.

https://doi.org/10.1182/blood-2023-174875

Published: 2023

Journal Articles

High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia

Josette M Kamel, Mendel Goldfinger, Jiani Chai, Jui Choudhuri, Marina Y. Konopleva, Eric J Feldman, Ioannis Mantzaris, Dennis L Cooper, Aditi Shastri, Nishi Shah, Noah Kornblum, Kira Gritsman, Alejandro Sica, Yanhua Wang, Xuejun Tian, Amit Verma, Swati Goel

Blood (2023) 142 (Supplement 1): 6050.

https://doi.org/10.1182/blood-2023-188243

Published: 2023

Journal Articles

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Nakul Singhal, MD, Rashi Sharma, MD, Ashwin Chandar, MD, Vincent McAuliffe, MD, Dennis L Cooper, MD

Blood (2016) 128 (22): 2412.

https://doi.org/10.1182/blood.V128.22.2412.2412

Published: 2016

Journal Articles

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Andrew R Branagan, MD, Eamon Duffy, Chandra Sekhar Boddupall, PhD, Randy A Albrecht, PhD, Lin Zhang, Rakesh Verma, PhD, Dennis L Cooper, MD, Stuart Seropian, MD, Terri L Parker, MD, Xiaopan Yao, PhD, Thomas M Ferencz, RPh, Madhav V Dhodapkar, MD

Blood (2015) 126 (23): 3058.

https://doi.org/10.1182/blood.V126.23.3058.3058

Published: 2015

Journal Articles

Cytotoxic and Gamma-Delta Subtypes Of Peripheral T-Cell Lymphoma: A Single Center Experience

Juliet Fraser, Antonio Subtil, MD, MBA, Onder Alpdogan, MD, Stuart Seropian, Dennis L. Cooper, MD, Mina Xu, MD, Francine M. Foss, MD

Blood (2013) 122 (21): 5092.

https://doi.org/10.1182/blood.V122.21.5092.5092

Published: 2013

Journal Articles

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Kartik Sehgal, MBBS, Mehmet H. Kocoglu, MD, Yanhong Deng, Rakesh Verma, Ph.D, Lin Zhang, Dennis L. Cooper, MD, Xiaopan Yao, Kavita Dhodapkar, MD, Madhav V. Dhodapkar, MD

Blood (2013) 122 (21): 3205.

https://doi.org/10.1182/blood.V122.21.3205.3205

Published: 2013

Journal Articles

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Nikolai A. Podoltsev, MD, PhD, Ivan Bustillo, MD, Xiaopan Yao, PhD, Haibei Liu, Dennis L. Cooper, MD

Blood (2011) 118 (21): 4941.

https://doi.org/10.1182/blood.V118.21.4941.4941

Published: 2011

Journal Articles

A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma.

Frederick Lansigan, MD, Stuart Seropian, MD, Dennis L. Cooper, MD, Von Potter, MD, Noelle Sowers, RN, Francine M Foss, MD

Blood (2010) 116 (21): 2816.

https://doi.org/10.1182/blood.V116.21.2816.2816

Published: 2010

Journal Articles

Brain Natriuretic Peptide (BNP) Elevations In Allogeneic Stem Cell Transplant (ASCT) Recipients at the Time of WBC Engraftment. Correlation with Engraftment Syndrome and Cardiac Dysfunction.

Iris Isufi, Amy Barile, Kerry Russell, Kasia Hryniewicz, Julie Baker, Erin Medoff, Daniel Jacoby, Forrester Lee, Francine M Foss, Dennis L. Cooper, Stuart Seropian

Blood (2010) 116 (21): 1309.

https://doi.org/10.1182/blood.V116.21.1309.1309

Published: 2010

Journal Articles

Stem Cell Mobilization Using 5 Pm Dosing of Plerixafor.

Dennis L Cooper, MD, Julie Baker, APRN, Erin Medoff, APRN, Kathryn Pratt, RN, Ann Conkling-Walsh, RN, Edward L. Snyder, MD, Stuart Seropian, MD, Francine Foss, MD

Blood (2009) 114 (22): 4233.

https://doi.org/10.1182/blood.V114.22.4233.4233

Published: 2009

Journal Articles

Sirolimus-Containing Graft-Versus-Host Disease Prophylaxis and High- Resolution HLA Typing Improves the Outcome of Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.

Ronald J. Maggiore, MD, Dennis L. Cooper, Francine M. Foss, Warren D. Shlomchik, Stuart E. Seropian

Blood (2008) 112 (11): 2216.

https://doi.org/10.1182/blood.V112.11.2216.2216

Published: 2008

Journal Articles

Outcomes in Subcutaneous Panniculitis-Like T-Cell Lymphoma (STCL)

Onder Alpdogan, MD, Deborah Ornstein, MD, Tony Subtil, MD, Stuart Seropian, MD, Dennis L. Cooper, MD, Francine Foss, MD

Blood (2008) 112 (11): 3750.

https://doi.org/10.1182/blood.V112.11.3750.3750

Published: 2008

Journal Articles

Successful Engraftment of Autologous Peripheral Blood Progenitor Cells Derived from Multiple Collections in Poor Mobilizers by Hyperstimulation with G-CSF.

YanYun Wu, MD, PhD, Maria A. Proytcheva, MD, Erin Medoff, RN, Stuart Seropian, MD, Edward L. Snyder, MD, Diane Krause, MD, PhD, Dennis L. Cooper, MD

Blood (2005) 106 (11): 5508.

https://doi.org/10.1182/blood.V106.11.5508.5508

Published: 2005

NARROW

A Weekly Low-Dose Regimen of Decitabine and Venetoclax is Efficacious and Less Myelotoxic in a Racially Diverse Cohort

A Study Evaluating Financial Toxicity Amongst Hematologic Malignancy Patients in the Bronx

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

Comparison of the Prognostic Performance of European Leukemianet 2017 and 2022 Classifications in a Minority-Rich Population of Adult Patients with Acute Myeloid Leukemia

Transportation Cost Is a Significant Barrier to Quality Care for Hematologic Malignancy Patients in a Minority-Rich, Socioeconomically Disadvantaged Population

Effective and Safe Molecular-Pharmacodynamic Once Weekly Dosing of Decitabine and Venetoclax Is a Highly Effective and Well-Tolerated Induction Therapy for AML: Interim Results of a Phase 2 Trial

Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study

High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders

Cytotoxic and Gamma-Delta Subtypes Of Peripheral T-Cell Lymphoma: A Single Center Experience

Comparison Of Intermittent and Continuous Dosing Regimens Of Pomalidomide In Relapsed/Refractory Myeloma: Results Of A Phase II Randomized Trial

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

A Phase 1 Trial of Vorinostat and Pegylated Liposomal Doxorubicin In Relapsed or Refractory Lymphoma.

Brain Natriuretic Peptide (BNP) Elevations In Allogeneic Stem Cell Transplant (ASCT) Recipients at the Time of WBC Engraftment. Correlation with Engraftment Syndrome and Cardiac Dysfunction.

Stem Cell Mobilization Using 5 Pm Dosing of Plerixafor.

Sirolimus-Containing Graft-Versus-Host Disease Prophylaxis and High- Resolution HLA Typing Improves the Outcome of Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation.

Outcomes in Subcutaneous Panniculitis-Like T-Cell Lymphoma (STCL)

Successful Engraftment of Autologous Peripheral Blood Progenitor Cells Derived from Multiple Collections in Poor Mobilizers by Hyperstimulation with G-CSF.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only